InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,244.80
(
0.36%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.96
(
0.91%
)
Bitcoin
61,405.73
(
-0.66%
)
Post# of 648143
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mc67

Send PM Follow Ignore
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

mc67

Re: None

Saturday, 08/22/2020 11:21:52 AM

Saturday, August 22, 2020 11:21:52 AM

Post# of 648143
$RLFTF Sounds like the FDA are liking the results and don't want to leave current lives at risk out..

"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials" -

From the Article in Bio-World

~ Money Making Money ~

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up